Header Logo

Kimberly Lenz

Concepts (82)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medicaid
10
2019
352
0.720
 Why?
Analgesics, Opioid
4
2019
508
0.600
 Why?
Pain
3
2019
406
0.580
 Why?
Medication Therapy Management
3
2018
25
0.400
 Why?
Antiviral Agents
3
2018
317
0.340
 Why?
Practice Patterns, Physicians'
5
2019
719
0.320
 Why?
Hepatitis C
2
2016
140
0.230
 Why?
United States
10
2019
7622
0.170
 Why?
Drug Utilization Review
2
2017
56
0.170
 Why?
Chloride Channel Agonists
1
2019
3
0.170
 Why?
Aminophenols
1
2019
4
0.170
 Why?
Drug and Narcotic Control
2
2017
30
0.170
 Why?
Benzodioxoles
1
2019
13
0.170
 Why?
Aminopyridines
1
2019
23
0.160
 Why?
Quinolones
1
2019
27
0.160
 Why?
Cystic Fibrosis
1
2019
108
0.150
 Why?
Uridine Monophosphate
1
2018
8
0.150
 Why?
Fluorenes
1
2018
13
0.150
 Why?
Medication Adherence
2
2017
254
0.150
 Why?
Benzimidazoles
1
2018
59
0.150
 Why?
Psychotropic Drugs
1
2018
83
0.140
 Why?
Insurance, Pharmaceutical Services
2
2014
24
0.140
 Why?
Hydrocodone
1
2017
6
0.140
 Why?
Hepatitis C, Chronic
1
2018
88
0.140
 Why?
Opioid-Related Disorders
2
2014
470
0.140
 Why?
Hepacivirus
1
2018
139
0.140
 Why?
Progesterone
1
2017
157
0.130
 Why?
Drug Prescriptions
1
2018
190
0.130
 Why?
Premature Birth
1
2017
108
0.130
 Why?
Lung
1
2019
842
0.120
 Why?
Prescription Drug Diversion
1
2014
7
0.120
 Why?
State Government
1
2014
32
0.110
 Why?
Prescription Drug Misuse
1
2014
22
0.110
 Why?
Drug Combinations
3
2019
138
0.110
 Why?
Drug Interactions
1
2014
113
0.110
 Why?
Managed Care Programs
1
2014
94
0.110
 Why?
Retrospective Studies
7
2018
6139
0.110
 Why?
Health Services Accessibility
1
2016
546
0.090
 Why?
Mental Disorders
1
2018
770
0.090
 Why?
Treatment Outcome
3
2016
5262
0.080
 Why?
Young Adult
4
2019
4396
0.070
 Why?
Adolescent
4
2019
5958
0.070
 Why?
Adult
6
2019
15985
0.070
 Why?
Humans
10
2019
60132
0.070
 Why?
Drug Costs
2
2016
59
0.060
 Why?
Cost Savings
2
2016
56
0.060
 Why?
Female
7
2019
31250
0.060
 Why?
Cost-Benefit Analysis
2
2017
303
0.060
 Why?
Middle Aged
5
2019
16535
0.060
 Why?
Pharmacists
2
2016
126
0.060
 Why?
Program Evaluation
2
2018
488
0.060
 Why?
Male
6
2019
27971
0.050
 Why?
Massachusetts
2
2018
2118
0.050
 Why?
Cohort Studies
2
2017
2479
0.040
 Why?
Child
2
2019
4336
0.040
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2019
75
0.040
 Why?
Sustained Virologic Response
1
2018
10
0.040
 Why?
Sofosbuvir
1
2018
18
0.040
 Why?
Ribavirin
1
2018
24
0.040
 Why?
Polypharmacy
1
2018
62
0.040
 Why?
Treatment Failure
1
2018
189
0.040
 Why?
Hydroxyprogesterones
1
2017
6
0.040
 Why?
Controlled Substances
1
2017
5
0.040
 Why?
Viral Load
1
2018
229
0.040
 Why?
Drug Therapy, Combination
1
2018
435
0.030
 Why?
Dose-Response Relationship, Drug
1
2019
807
0.030
 Why?
RNA, Viral
1
2018
265
0.030
 Why?
Gestational Age
1
2017
184
0.030
 Why?
Psychiatry
1
2018
129
0.030
 Why?
Genotype
1
2018
643
0.030
 Why?
Insurance Claim Review
1
2016
80
0.030
 Why?
Evidence-Based Medicine
1
2018
457
0.030
 Why?
Pregnancy Outcome
1
2017
189
0.030
 Why?
Government Regulation
1
2014
44
0.030
 Why?
Interdisciplinary Communication
1
2014
107
0.030
 Why?
Physician's Role
1
2014
120
0.030
 Why?
Cooperative Behavior
1
2014
220
0.030
 Why?
Health Policy
1
2014
183
0.020
 Why?
Mutation
1
2019
2471
0.020
 Why?
Pregnancy
1
2017
2367
0.020
 Why?
Time Factors
1
2014
3618
0.020
 Why?
Aged
1
2018
13581
0.010
 Why?
Lenz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_